Overview

Prazosin Use in Adults With Anxiety Disorders

Status:
Suspended
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Prazosin has shown effectiveness in treating Post-Traumatic Stress Disorder through improving sleep quality and global functioning. Given the significant evidence for its utility in treating PTSD, in combination with the fact that many anxiety symptoms overlap with PTSD (e.g.insomnia, hyperarousal, and irritability), it is essential to evaluate its potential effectiveness in treating symptoms of other anxiety disorder and patient tolerability.
Phase:
Phase 1
Details
Lead Sponsor:
University of Manitoba
Treatments:
Prazosin